A number of studies have found that upregulation of STEAP3 is strongly associated with poor prognosis in triple-negative breast cancer as well as gliomas, suggesting that STEAP3 may be used as a specific predictor [13, 14]. The gene discussed is STEAP3; the disease is triple-negative breast carcinoma.